ACC 2023 Conference Coverage
H

ACC 2023: Considerations for Anti-Platelet and Anti-Thrombotic Therapy After TAVR

By ACC 2023 Conference Coverage FEATURING Howard Herrmann
By ACC 2023 Conference Coverage FEATURING Howard Herrmann
0 views
March 9, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
36:11
ARCH Advanced Revascularization Symposium

The UPSTREAM Management of Aortic Stenosis in the Future

Feat. M. Leon
09:48
American College of Cardiology

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

Feat. D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy
12:41
ARCH Advanced Revascularization Symposium

CAD and Aortic Stenosis: Just Treat the Valve (Most of the Time)

Feat. M. Chung
10:13
Complex Coronary Cases

Lp(a): The New Kid on the Block

Feat. P. Taub
07:38
University of Miami

First-in-man Use of Electrosurgical SESAME (SEptal Scoring Along the…

Feat. C. Sanina
21:57
University of Miami

The Future of TAVR - Where Will We Be In 2030? My Crystal Ball

Feat. E. Grube
16:00
The North American Thrombosis Forum (NATF)

Structural Heart Disease in Pregnant Women: Risk Stratification and …

Feat. A. Valente
15:40
New York Transcatheter Valves 2022

Latest Update on Valvular Heart Disease: Strides Made, Looking to th…

Feat. R. Bonow
23:16
Penn Medicine Heart and Vascular Center

Bicuspid Aortic Valve Disease: Strategies in Young Patients Includin…

Feat. J. Bavaria
18:55
New York Transcatheter Valves 2019

Valvular Heart Disease and Aortic Stenosis Management in 2020: What …

Feat. R. Nishimura
11:48
New York Transcatheter Valves 2021

TAVR + CAD: Rationale & Update on COMPLETE TAVR Trial

Feat. D. Wood
20:04
Scripps Health

Quantification of AS and AI Severity by Echo

Feat. M. Picard
16:23
Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes

Lipoprotein(a) – Target for Personalized Prevention of Aortic Stenos…

Feat. C. Yeang
26:08
Cedars Sinai

Upstream Treatment of Aortic Stenosis

Feat. M. Leon
28:54
Michigan Medicine

Echo Assessment of Valvular Disease

Feat. S. Kohnstamm
11:54
4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention

Aortic Stenosis in a Low Risk Surgical Patient: Is TAVR the First Ch…

Feat. L. Pirelli
19:23
Jefferson Health

Current Guidelines for the Management of Aortic Valve Disease

Feat. G. Pressman
21:40
The Texas Heart Institute

Silent Leaflet Thrombosis After TAVR: Is Absence of Anticoagulation …

Feat. Z. Krajcer
15:05
Igor F. Palacios, MD Lectureship and Symposium

Antithrombotic Therapy After TAVR

Feat. A. Caldera